Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06189313 · ClinicalTrials.gov registry record · NA
CLEANer Aspiration for Pulmonary Embolism
A NA study of Cardiovascular Diseases and Pulmonary Embolism, sponsored by Argon Medical Devices.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 14
- Study locations
NCT06189313: Recruiting NA study of Cardiovascular Diseases and Pulmonary Embolism, sponsored by Argon Medical Devices.
NCT06189313 is a NA study of Cardiovascular Diseases and Pulmonary Embolism that is actively recruiting participants, run by Argon Medical Devices. The registered enrollment target is 125 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 14 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06189313, a NA study of Cardiovascular Diseases and Pulmonary Embolism, is actively recruiting participants, sponsored by Argon Medical Devices.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 14
- Study locations
Study Summary
To evaluate the safety and efficacy of the Cleaner™ Pro Thrombectomy System for aspiration thrombectomy in patients with acute pulmonary embolism (PE).
Conditions Studied
Interventions
- DEVICE Cleaner Pro Thrombectomy System
Study Locations (14)
Ohio
- University of Cincinnati - Cincinnati
- Cleveland Clinic - Cleveland
- Promedica Toledo Hospital - Toledo
Florida
- Ascension Sacred Heart Hospital - Pensacola
- BayCare Health System - Tampa
Texas
- Baylor Scott and White Heart and Vascular Hospital - Dallas - Dallas
- Baylor Scott & White The Heart Hospital - Plano - Plano
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
District of Columbia
- Medstar Health Research Institute - Washington D.C.
Illinois
- Insight Hospital and Medical Center - Chicago
Indiana
- Ascension St. Vincent Hospital - Indianapolis
Massachusetts
- UMass Chan Medical School - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2025-01-03 |
| Est. Completion | 2027-09-02 |
| Phase | NA |
What NCT06189313 shows while recruiting
NCT06189313 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Cleaner Pro Thrombectomy System is the first listed.
NCT06189313 lists 14 locations in 10 states (Ohio, Florida, Texas).
Frequently Asked Questions
What is clinical trial NCT06189313 about?
NCT06189313 is a clinical study titled "CLEANer Aspiration for Pulmonary Embolism". To evaluate the safety and efficacy of the Cleaner™ Pro Thrombectomy System for aspiration thrombectomy in patients with acute pulmonary embolism (PE).
What is the current status of trial NCT06189313?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-01-03. Estimated completion is 2027-09-02.
What conditions does trial NCT06189313 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Pulmonary Embolism, Venous Thromboembolism, Acute Pulmonary Embolism.
What interventions are being tested in trial NCT06189313?
The interventions under investigation include: Cleaner Pro Thrombectomy System (DEVICE).
Who is sponsoring clinical trial NCT06189313?
This trial is sponsored by Argon Medical Devices, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06189313 being conducted?
This trial has 14 study locations across Colorado, District of Columbia, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06189313's enrollment target sits among peer trials
125 177th of 300 higher than 123 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI